BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919
55 results:

  • 1. Targeting lef1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
    Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
    Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
    Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
    J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression.
    Yang B; Zhang J; Wang J; Fan W; Barbier-Torres L; Yang X; Justo MAR; Liu T; Chen Y; Steggerda J; Ramani K; Lu SC; Yang H
    Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37347224
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1.
    Hu J; Liu WF; Zhang XY; Shi GM; Yang XR; Zhou KQ; Hu B; Chen FY; Zhou C; Lau WY; Fan J; Wang Z; Zhou J
    Hepatol Int; 2023 Oct; 17(5):1265-1278. PubMed ID: 37115456
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Possible Mechanism of Dysphania ambrosioides (L.) Mosyakin & Clemants Seed Extract Suppresses the Migration and Invasion of Human Hepatocellular Carcinoma Cells SMMC-7721.
    Huang J; Hao J; Nie J; Qian R; Li H; Zhao J; Wang Y
    Chem Biodivers; 2023 Mar; 20(3):e202200768. PubMed ID: 36694378
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. In vitro and Pharmacoinformatics-based phytochemical screening for anticancer impacts of pistachio hull essential oil on AGS, PLC/PRF/5, and CACO2 cell lines.
    Askari N; Parvizpour S; Marashi SMB; Baghery F; Khanamani Falahati-Pour S
    Mol Biol Rep; 2023 Jan; 50(1):465-473. PubMed ID: 36348196
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting lef1 and suppressing Wnt/β-catenin signaling.
    Chen X; Tu J; Liu C; Wang L; Yuan X
    Life Sci; 2022 Nov; 308():120941. PubMed ID: 36087740
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma.
    Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S
    Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy.
    Wan JL; Wang B; Wu ML; Li J; Gong RM; Song LN; Zhang HS; Zhu GQ; Chen SP; Cai JL; Xing XX; Wang YD; Yang Y; Cai CZ; Huang R; Liu H; Dai Z
    Cancer Lett; 2022 Aug; 541():215750. PubMed ID: 35609735
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. "Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms.
    Mattiolo P; Mafficini A; Lawlor RT; Marchegiani G; Malleo G; Pea A; Salvia R; Piccoli P; Sciammarella C; Santonicco N; Parisi A; Silvestris N; Milella M; Adsay V; Scarpa A; Luchini C
    Virchows Arch; 2022 Jul; 481(1):41-47. PubMed ID: 35359182
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis.
    Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S
    J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.
    Shirin M; Madadi S; Peyravian N; Pezeshkian Z; Rejali L; Hosseini M; Moradi A; Khanabadi B; Sherkat G; Aghdaei HA; Nazemalhosseini-Mojarad E
    Med Oncol; 2022 Jan; 39(4):40. PubMed ID: 35092502
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis.
    Lin CS; Liang Y; Su SG; Zheng YL; Yang X; Jiang N; Fu L; Zhou J; Zhang Y; Deng R; Wang CH; Lu SX; Huang YH; Liu LL; Zhang C; Yun JP
    Cancer Lett; 2022 Feb; 526():236-247. PubMed ID: 34767927
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. LncRNA lef1-AS1/lef1/FUT8 Axis Mediates Colorectal cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
    Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
    Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long noncoding RNA lef1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effects of aspirin on hepatocellular carcinoma and its potential molecular mechanism.
    Yuan Z; Zhao J; Wang Z; Ren G; Zhang Z; Ma G
    J BUON; 2020; 25(2):981-986. PubMed ID: 32521895
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
    Ragheb MA; Soliman MH; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
    Anticancer Agents Med Chem; 2021; 21(2):237-245. PubMed ID: 32357822
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/
    Chen J; Wang M; Xiang Y; Ru X; Ren Y; Liu X; Qiu L; Zhang Y
    Oxid Med Cell Longev; 2020; 2020():5138539. PubMed ID: 32273945
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. LncRNA lef1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Silencing of long noncoding RNA lef1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.